Lisa A. Adams - Concepedia

Author

Lisa A. Adams

Eli Lilly (United States)

Also Known As

Lisa A. Adams, Lisa Adams

Publications

232

Citations

H-Index

Concepts

All Affiliations

Eli Lilly (United States)

About

Lisa A. Adams is an author at Eli Lilly (United States) specializing in drug discovery, medicine, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	109
2	Natural Sciences	2	2	61
3	Biochemistry	2	2	61
4	Health Sciences	1	1	22
5	Chemical Biology	1	1	31

Lisa A. Adams

Publications

215

Citations

H-Index

Page 1

	Year	Citations
The exenatide analogue AC3174 attenuates hypertension, insulin resistance, and renal dysfunction in Dahl salt-sensitive rats Que Liu, Lisa A. Adams, Anatoly Broyde, Cardiovascular Diabetology	2010	65
Imidazopyridine and Pyrazolopiperidine Derivatives as Novel Inhibitors of Serine Palmitoyl Transferase Michaël Génin, Isabel C. Gonzalez Valcarcel, William G. Holloway, Journal of Medicinal Chemistry Bioorganic ChemistryPharmacotherapyChemical BiologyInsulin SignalingPharmaceutical Chemistry	2016	31
Discovery of LY3104607: A Potent and Selective G Protein-Coupled Receptor 40 (GPR40) Agonist with Optimized Pharmacokinetic Properties to Support Once Daily Oral Treatment in Patients with Type 2 Diabetes Mellitus Chafiq Hamdouchi, Pranab Maiti, Alan M. Warshawsky, Journal of Medicinal Chemistry Fused HeterocyclesPharmacotherapyMedicinal ChemistryPotent Gpr40Insulin Delivery	2017	30
Difference in the Pharmacokinetics and Hepatic Metabolism of Antidiabetic Drugs in Zucker Diabetic Fatty and Sprague-Dawley Rats Xin Zhou, L. Rougée, David W. Bedwell, Drug Metabolism and Disposition	2016	27
Identification of Potent and Selective Hydantoin Inhibitors of Aggrecanase-1 and Aggrecanase-2 That Are Efficacious in Both Chemical and Surgical Models of Osteoarthritis Timothy B. Durham, Valentine J. Klimkowski, Christopher J. Rito, Journal of Medicinal Chemistry SclerostinOsteoporosisOrthopaedic SurgeryMusculoskeletal ResearchInflammation	2014	26
Identification of potent and selective retinoic acid receptor gamma (RARγ) antagonists for the treatment of osteoarthritis pain using structure based drug design Norman E. Hughes, Thomas J. Bleisch, Scott A. Jones, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyOsteoarthritis PainAnti-inflammatoryHealth SciencesPain Medicine	2016	22
A Highly Selective Hydantoin Inhibitor of Aggrecanase-1 and Aggrecanase-2 with a Low Projected Human Dose Timothy B. Durham, Jothirajah Marimuthu, James L. Toth, Journal of Medicinal Chemistry	2017	14

Page 1